The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictors of post-transplant survival in patients with newly diagnosed acute myeloid leukemia receiving frontline venetoclax and hypomethylating agents.
 
Isla Johnson
No Relationships to Disclose
 
Azeem Elbeih
No Relationships to Disclose
 
Nour Ghosoun
No Relationships to Disclose
 
Kristen McCullough
No Relationships to Disclose
 
Aref Al-Kali
Consulting or Advisory Role - Novartis (Inst)
Research Funding - Ambit BioSciences (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); Bristol Myers Squibb Foundation (Inst); Celgene (Inst); H3 Biomedicine (Inst); MedImmune (Inst); Novartis (Inst); Onconova Therapeutics (Inst)
 
Hassan Alkhateeb
No Relationships to Disclose
 
Kebede Begna
Consulting or Advisory Role - Novartis/Pfizer
Research Funding - IMGN632 (Inst); MEI Pharma (Inst)
 
Michelle Elliott
No Relationships to Disclose
 
Abhishek Mangaonkar
Research Funding - Bristol Myers Squibb Foundation (Inst); Gilead Sciences (Inst); Incyte (Inst); Novartis (Inst)
 
Aasiya Matin
No Relationships to Disclose
 
Antoine Saliba
Research Funding - Chordia Therapeutics (Inst); Kura Oncology (Inst)
 
Mehrdad Hefazi
No Relationships to Disclose
 
William Hogan
Research Funding - Seres Therapeutics (Inst)
 
Mithun Shah
Research Funding - Astellas Amgen BioPharama (Inst); Celgene (Inst); Marker Therapeutics (Inst)
 
Mrinal Patnaik
Consulting or Advisory Role - Kura Oncology (Inst)
Research Funding - Epigenetix (Inst); Kura Oncology (Inst); Polaris (Inst); Solutherapeutics (Inst); Stemline Therapeutics (Inst)
 
Animesh Pardanani
No Relationships to Disclose
 
Mark Litzow
Honoraria - Amgen; BeiGene Shanghai
Speakers' Bureau - Amgen; BeiGene Shanghai
Research Funding - Actinium Pharmaceuticals (Inst); Amgen (Inst); Astellas Amgen BioPharama (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - Amgen; BeiGene Shanghai
Other Relationship - Biosight
 
Ayalew Tefferi
No Relationships to Disclose
 
Naseema Gangat
Consulting or Advisory Role - Agios; Disc Medicine